{"DataElement":{"publicId":"10672198","version":"1","preferredName":"Union for International Cancer Control Staging System Pathologic Regional Lymph Nodes TNM Finding Category","preferredDefinition":"The response indicating the pathological stage of the regional lymph nodes using the Union for International Cancer Control staging system as a basis for evaluation of the disease.","longName":"10544807v1.00:10544818v1.00","context":"OCG","contextVersion":"1","DataElementConcept":{"publicId":"10544807","version":"1","preferredName":"Union for International Cancer Control Staging System Pathologic Regional Lymph Nodes TNM Finding","preferredDefinition":"_The International Union Against Cancer (UICC) is the only global cancer organisation with members and activities covering all aspects of cancer control. Founded in 1933, UICC is an independent, international, non-governmental association of 291 member cancer fighting organizations in 87 countries. Located in Geneva, Switzerland._A system for clinicopathologic evaluation of tumors based on the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion), and lymph node involvement (N) and metastasis (M) each followed by a number starting at 0 for no evident metastasis; numbers used depend on the organ involved and influence the prognosis and choice of treatment:A pathologic finding about one or more characteristics of a specific cancer, following the rules of the TNM classification system as they pertain to staging of regional lymph nodes.","longName":"10544806v1.00:2236665v1.00","context":"OCG","contextVersion":"1","ObjectClass":{"publicId":"10544794","version":"1","preferredName":"International Union Against Cancer TNM Staging System","preferredDefinition":"The International Union Against Cancer (UICC) is the only global cancer organisation with members and activities covering all aspects of cancer control. Founded in 1933, UICC is an independent, international, non-governmental association of 291 member cancer fighting organizations in 87 countries. Located in Geneva, Switzerland._A system for clinicopathologic evaluation of tumors based on the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion), and lymph node involvement (N) and metastasis (M) each followed by a number starting at 0 for no evident metastasis; numbers used depend on the organ involved and influence the prognosis and choice of treatment.","longName":"C39434:C25384","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Union for International Cancer Control","conceptCode":"C39434","definition":"A global cancer organisation comprising over 1200 organisations in 172 countries with activities covering all aspects of cancer control. It was founded in 1933 as the International Union Against Cancer. The organisation is dedicated to taking the lead in convening, capacity building and advocacy initiatives that unite and support the cancer community to reduce the global cancer burden, promote greater equity, and to ensure cancer control continues to be a priority in the world health and development agenda.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"TNM Staging System","conceptCode":"C25384","definition":"A system for clinicopathologic evaluation of tumors based on the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion), and lymph node involvement (N) and metastasis (M) each followed by a number starting at 0 for no evident metastasis; numbers used depend on the organ involved and influence the prognosis and choice of treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E26DC616-3514-67B5-E053-731AD00AD545","latestVersionIndicator":"Yes","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"10544809","version":"1","preferredName":"Pathologic Regional Lymph Nodes TNM Finding","preferredDefinition":"A pathologic finding about one or more characteristics of a specific cancer, following the rules of the TNM classification system as they pertain to staging of regional lymph nodes.","longName":"C48887","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Regional Lymph Nodes TNM Finding","conceptCode":"C48887","definition":"A pathologic finding about one or more characteristics of a specific cancer, following the rules of the TNM classification system as they pertain to evaluating regional lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2763C89-3DC5-66F9-E053-731AD00A305B","latestVersionIndicator":"Yes","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"UICC Based:Staging Criteria Based on Union for International Cancer Control","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2763C89-3DC3-66F9-E053-731AD00A305B","latestVersionIndicator":"Yes","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-07-22","changeDescription":null,"administrativeNotes":"07.22.22_Curated to support UICC data capture_ghd","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"10544818","version":"1","preferredName":"Pathologic Regional Lymph Nodes TNM Finding Category","preferredDefinition":"A pathologic finding about one or more characteristics of a specific cancer, following the rules of the TNM classification system as they pertain to staging of regional lymph nodes._A grouping of items based on some commonality or by user defined characteristics.","longName":"10544818v1.00","context":"OCG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"25","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"N0","valueDescription":null,"ValueMeaning":{"publicId":"3202490","version":"1","preferredName":"N0 Stage Finding","longName":"3202490","preferredDefinition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N0 TNM Finding","conceptCode":"C48705","definition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E2724CD-0CF7-2CEC-E040-BB89AD437A31","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"GDEEN","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3550-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"N0 (i+)","valueDescription":null,"ValueMeaning":{"publicId":"3202524","version":"1","preferredName":"N0 (i+) Stage Finding","longName":"3202524","preferredDefinition":"A regional lymph node TNM finding indicating that there are malignant cells in regional lymph node(s) no greater than 0.2 mm and are detected by hematoxylin and eosin stain or immunohistochemistry.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pN0 (i+) TNM Finding","conceptCode":"C95922","definition":"A regional lymph node TNM finding indicating that there are malignant cells in regional lymph node(s) no greater than 0.2 mm and are detected by hematoxylin and eosin stain or immunohistochemistry.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E27C2B1-4AA8-99F4-E040-BB89AD432C85","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3551-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"N0 (i-)","valueDescription":null,"ValueMeaning":{"publicId":"3202525","version":"1","preferredName":"N0 (i-) Stage Finding","longName":"3202525","preferredDefinition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis histologically, and immunohistochemistry is negative.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pN0 (i-) TNM Finding","conceptCode":"C95921","definition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis histologically, and immunohistochemistry is negative.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E27C2B1-4ACD-99F4-E040-BB89AD432C85","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3552-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"N0 (mol+)","valueDescription":null,"ValueMeaning":{"publicId":"3202522","version":"1","preferredName":"N0 (mol+) Stage Finding","longName":"3202522","preferredDefinition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis histologically and by immunohistochemistry, but the molecular analysis (RT-PCR) is positive.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pN0 (mol+) TNM Finding","conceptCode":"C95925","definition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis histologically and by immunohistochemistry, but the molecular analysis (RT-PCR) is positive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E27C2B1-4A5E-99F4-E040-BB89AD432C85","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3553-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"N0 (mol-)","valueDescription":null,"ValueMeaning":{"publicId":"3202523","version":"1","preferredName":"N0 (mol-) Stage Finding","longName":"3202523","preferredDefinition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis histologically and molecular analysis (RT-PCR) is negative.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pN0 (mol-) TNM Finding","conceptCode":"C95923","definition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis histologically and molecular analysis (RT-PCR) is negative.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E27C2B1-4A83-99F4-E040-BB89AD432C85","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3554-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"N1","valueDescription":null,"ValueMeaning":{"publicId":"3906574","version":"1","preferredName":"N1 Stage Finding","longName":"3906574","preferredDefinition":"A general term that refers to a TNM finding of cancer metastases usually in a limited number of regional lymph nodes. The definition of N1 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to micrometastases or metastases in 1-3 axillary lymph nodes; for cutaneous melanoma it refers to metastasis in 1 regional lymph node; for colorectal cancer it refers to metastases in 1-3 regional lymph nodes; and for bladder cancer it refers to metastasis in 1 regional lymph node in the true pelvis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N1 TNM Finding","conceptCode":"C48706","definition":"A general term that refers to a TNM finding of cancer metastases usually in a limited number of regional lymph nodes. The definition of N1 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to micrometastases or metastases in 1-3 axillary lymph nodes; for cutaneous melanoma it refers to metastasis in 1 regional lymph node; for colorectal cancer it refers to metastases in 1-3 regional lymph nodes; and for bladder cancer it refers to metastasis in 1 regional lymph node in the true pelvis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E723165B-9D68-76D4-E040-BB89AD436665","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"PATELV","dateCreated":"2013-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3555-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"N1a","valueDescription":null,"ValueMeaning":{"publicId":"5654386","version":"1","preferredName":"N1a Stage Finding","longName":"5654386","preferredDefinition":"A general term that refers to a TNM finding of cancer metastases usually in a limited number of regional lymph nodes. The definition of N1a TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastasis in 1 to 3 axillary lymph nodes (at least 1 tumor deposit greater than 2.0 mm); for cutaneous melanoma it refers to micrometastasis in one regional lymph node; for colorectal cancer it refers to metastasis in one regional lymph node.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N1a TNM Finding","conceptCode":"C48707","definition":"A general term that refers to a TNM finding of cancer metastases usually in a limited number of regional lymph nodes. The definition of N1a TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastasis in 1 to 3 axillary lymph nodes (at least 1 tumor deposit greater than 2.0 mm); for cutaneous melanoma it refers to micrometastasis in one regional lymph node; for colorectal cancer it refers to metastasis in one regional lymph node.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"47DEFD19-9CCD-7921-E053-F662850AFEAD","latestVersionIndicator":"Yes","beginDate":"2017-02-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-02-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3556-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"N1b","valueDescription":null,"ValueMeaning":{"publicId":"5654385","version":"1","preferredName":"N1b Stage Finding","longName":"5654385","preferredDefinition":"A general term that refers to a TNM finding of cancer metastases usually in a limited number of regional lymph nodes. The definition of N1b TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in internal mammary lymph nodes with micrometastases or macrometastases detected by sentinel lymph node biopsy but not clinically detected; for cutaneous melanoma it refers to macrometastasis in one regional lymph node; for colorectal cancer it refers to metastasis in 2-3 regional lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N1b TNM Finding","conceptCode":"C48708","definition":"A general term that refers to a TNM finding of cancer metastases usually in a limited number of regional lymph nodes. The definition of N1b TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in internal mammary lymph nodes with micrometastases or macrometastases detected by sentinel lymph node biopsy but not clinically detected; for cutaneous melanoma it refers to macrometastasis in one regional lymph node; for colorectal cancer it refers to metastasis in 2-3 regional lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"47DEFD19-9CAA-7921-E053-F662850AFEAD","latestVersionIndicator":"Yes","beginDate":"2017-02-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-02-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3557-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"N1bI","valueDescription":null,"ValueMeaning":{"publicId":"3202521","version":"1","preferredName":"N1bI Stage Finding","longName":"3202521","preferredDefinition":"A regional lymph node TNM finding indicating that there is metastasis to 1-3 nodes.  The metastasis is greater than 2 mm and all are less than 20 mm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N1bI Stage Finding","conceptCode":"C95929","definition":"A regional lymph node TNM finding indicating that there is metastasis to 1-3 nodes.  The metastasis is greater than 2 mm and all are less than 20 mm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E27C2B1-4A39-99F4-E040-BB89AD432C85","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3558-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"N1bII","valueDescription":null,"ValueMeaning":{"publicId":"3202520","version":"1","preferredName":"N1bII Stage Finding","longName":"3202520","preferredDefinition":"A regional lymph node TNM finding indicating that there is metastasis to four or more nodes.  The metastasis is greater than 2 mm and all are less than 20 mm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N1bII Stage Finding","conceptCode":"C95935","definition":"A regional lymph node TNM finding indicating that there is metastasis to four or more nodes.  The metastasis is greater than 2 mm and all are less than 20 mm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E27C2B1-4A14-99F4-E040-BB89AD432C85","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3559-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"N1bIII","valueDescription":null,"ValueMeaning":{"publicId":"3202519","version":"1","preferredName":"N1bIII Stage Finding","longName":"3202519","preferredDefinition":"A regional lymph node TNM finding indicating that the tumor extends beyond the lymph node capsule and is less than 20 mm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N1bIII Stage Finding","conceptCode":"C95936","definition":"A regional lymph node TNM finding indicating that the tumor extends beyond the lymph node capsule and is less than 20 mm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E27C2B1-49EF-99F4-E040-BB89AD432C85","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-355B-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"N1bIV","valueDescription":null,"ValueMeaning":{"publicId":"3202518","version":"1","preferredName":"N1bIV Stage Finding","longName":"3202518","preferredDefinition":"A regional lymph node TNM finding indicating that the metastases to the lymph nodes are more than 20 mm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N1bIV Stage Finding","conceptCode":"C95937","definition":"A regional lymph node TNM finding indicating that the metastases to the lymph nodes are more than 20 mm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E27C2B1-49CA-99F4-E040-BB89AD432C85","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-355C-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"N1c","valueDescription":null,"ValueMeaning":{"publicId":"5654384","version":"1","preferredName":"N1c Stage Finding","longName":"5654384","preferredDefinition":"A general term that refers to a TNM finding of cancer metastases usually in a limited number of regional lymph nodes. The definition of N1c TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 1 to 3 axillary lymph nodes and in internal mammary lymph nodes with micrometastases or macrometastases detected by sentinel lymph node biopsy but not clinically detected; for colorectal cancer it refers to tumor deposit(s) in the subserosa, mesentery, or nonperitonealized pericolic or perirectal tissues without regional lymph node metastasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N1c TNM Finding","conceptCode":"C48709","definition":"A general term that refers to a TNM finding of cancer metastases usually in a limited number of regional lymph nodes. The definition of N1c TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 1 to 3 axillary lymph nodes and in internal mammary lymph nodes with micrometastases or macrometastases detected by sentinel lymph node biopsy but not clinically detected; for colorectal cancer it refers to tumor deposit(s) in the subserosa, mesentery, or nonperitonealized pericolic or perirectal tissues without regional lymph node metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"47DEFD19-9C87-7921-E053-F662850AFEAD","latestVersionIndicator":"Yes","beginDate":"2017-02-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-02-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-355D-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"N1mi","valueDescription":null,"ValueMeaning":{"publicId":"10544826","version":"1","preferredName":"N1mi Stage Finding","longName":"10544826v1.00","preferredDefinition":"A regional lymph node TNM finding indicating the presence of micrometastases (greater than 0.2 mm and/or more than 200 cells, but none greater than 2.0 mm).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N1mi TNM Finding","conceptCode":"C95955","definition":"A regional lymph node TNM finding indicating the presence of micrometastases (greater than 0.2 mm and/or more than 200 cells, but none greater than 2.0 mm).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E26DC616-355A-67B5-E053-731AD00AD545","latestVersionIndicator":"Yes","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-355E-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"N2","valueDescription":null,"ValueMeaning":{"publicId":"3202495","version":"1","preferredName":"N2 Stage Finding","longName":"3202495","preferredDefinition":"A general term that refers to a TNM finding of cancer metastases in several regional lymph nodes. The definition of N2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 4-9 axillary lymph nodes; for cutaneous melanoma it refers to metastases in 2-3 regional lymph nodes; for colorectal cancer it refers to metastases in 4 or more regional lymph nodes; and for bladder cancer it refers to metastases in multiple regional lymph nodes in the true pelvis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N2 TNM Finding","conceptCode":"C48786","definition":"A general term that refers to a TNM finding of cancer metastases in several regional lymph nodes. The definition of N2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 4-9 axillary lymph nodes; for cutaneous melanoma it refers to metastases in 2-3 regional lymph nodes; for colorectal cancer it refers to metastases in 4 or more regional lymph nodes; and for bladder cancer it refers to metastases in multiple regional lymph nodes in the true pelvis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E2724CD-0DAC-2CEC-E040-BB89AD437A31","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-355F-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"N2a","valueDescription":null,"ValueMeaning":{"publicId":"3202496","version":"1","preferredName":"N2a Stage Finding","longName":"3202496","preferredDefinition":"A general term that refers to a TNM finding of cancer metastases in several regional lymph nodes.  The definition of N2a TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 4 to 9 axillary lymph nodes (at least 1 tumor deposit greater than 2.0 mm); for cutaneous melanoma it refers to micrometastases in 2-3 regional lymph nodes; for colorectal cancer it refers to metastases in 4-6 regional lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N2a TNM Finding","conceptCode":"C48711","definition":"A general term that refers to a TNM finding of cancer metastases in several regional lymph nodes.  The definition of N2a TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 4 to 9 axillary lymph nodes (at least 1 tumor deposit greater than 2.0 mm); for cutaneous melanoma it refers to micrometastases in 2-3 regional lymph nodes; for colorectal cancer it refers to metastases in 4-6 regional lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E2724CD-0DD1-2CEC-E040-BB89AD437A31","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3560-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"N2b","valueDescription":null,"ValueMeaning":{"publicId":"3202497","version":"1","preferredName":"N2b Stage Finding","longName":"3202497","preferredDefinition":"A general term that refers to a TNM finding of cancer metastases in several regional lymph nodes.  The definition of N2b TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases only in clinically detected ipsilateral internal mammary nodes and in the absence of clinically evident level I, II axillary lymph node metastases; for cutaneous melanoma it refers to macrometastases in 2-3 regional lymph nodes; for colorectal cancer it refers to metastases in seven or more regional lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N2b TNM Finding","conceptCode":"C48712","definition":"A general term that refers to a TNM finding of cancer metastases in several regional lymph nodes.  The definition of N2b TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases only in clinically detected ipsilateral internal mammary nodes and in the absence of clinically evident level I, II axillary lymph node metastases; for cutaneous melanoma it refers to macrometastases in 2-3 regional lymph nodes; for colorectal cancer it refers to metastases in seven or more regional lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E2724CD-0DF6-2CEC-E040-BB89AD437A31","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3561-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"N2c","valueDescription":null,"ValueMeaning":{"publicId":"3342463","version":"1","preferredName":"N2c Stage Finding","longName":"3342463","preferredDefinition":"A general term that refers to a TNM finding of cancer metastases in several regional lymph nodes.  The definition of N2c TNM finding depends on the specific type of cancer that it refers to; for example, for cutaneous melanoma it refers to intralymphatic metastases (in transit or satellite metastases) without metastatic nodes; for lip and oral cavity cancer it refers to metastases in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N2c TNM Finding","conceptCode":"C48713","definition":"A general term that refers to a TNM finding of cancer metastases in several regional lymph nodes.  The definition of N2c TNM finding depends on the specific type of cancer that it refers to; for example, for cutaneous melanoma it refers to intralymphatic metastases (in transit or satellite metastases) without metastatic nodes; for lip and oral cavity cancer it refers to metastases in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B5A4E919-D7F6-0005-E040-BB89AD430ABD","latestVersionIndicator":"Yes","beginDate":"2012-01-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3562-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"N3","valueDescription":null,"ValueMeaning":{"publicId":"3202498","version":"1","preferredName":"N3 Stage Finding","longName":"3202498","preferredDefinition":"A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes. The definition of N3 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 10 or more axillary lymph nodes; for cutaneous melanoma it refers to metastases in 4 or more regional lymph nodes; for gastric cancer it refers to metastases in 7 or more regional lymph nodes; and for bladder cancer it refers to metastases in common iliac lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N3 TNM Finding","conceptCode":"C48714","definition":"A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes. The definition of N3 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 10 or more axillary lymph nodes; for cutaneous melanoma it refers to metastases in 4 or more regional lymph nodes; for gastric cancer it refers to metastases in 7 or more regional lymph nodes; and for bladder cancer it refers to metastases in common iliac lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E2724CD-0E19-2CEC-E040-BB89AD437A31","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3563-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"N3a","valueDescription":null,"ValueMeaning":{"publicId":"3202499","version":"1","preferredName":"N3a Stage Finding","longName":"3202499","preferredDefinition":"A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes.  The definition of N3a TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 10 or more axillary lymph nodes (at least one tumor deposit greater than 2.0 mm) or metastases to the infraclavicular (level III axillary) lymph nodes; for gastric cancer it refers to metastases in 7-15 regional lymph nodes; for nasopharyngeal cancer it refers to metastases to one or more lymph nodes greater than 6 cm in greatest dimension.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N3a TNM Finding","conceptCode":"C48715","definition":"A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes.  The definition of N3a TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 10 or more axillary lymph nodes (at least one tumor deposit greater than 2.0 mm) or metastases to the infraclavicular (level III axillary) lymph nodes; for gastric cancer it refers to metastases in 7-15 regional lymph nodes; for nasopharyngeal cancer it refers to metastases to one or more lymph nodes greater than 6 cm in greatest dimension.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E2724CD-0E3E-2CEC-E040-BB89AD437A31","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3564-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"N3b","valueDescription":null,"ValueMeaning":{"publicId":"3202500","version":"1","preferredName":"N3b Stage Finding","longName":"3202500","preferredDefinition":"A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes.  The definition of N3b TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in clinically detected ipsilateral internal mammary lymph nodes in the presence of  one or more positive axillary lymph nodes, or in more than 3 axillary lymph nodes and in internal mammary lymph nodes with micrometastases or macrometastases detected by sentinel lymph node biopsy but not clinically detected; for gastric cancer it refers to metastases in sixteen or more regional lymph nodes; for nasopharyngeal cancer it refers to extension to the supraclavicular fossa.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N3b TNM Finding","conceptCode":"C48716","definition":"A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes.  The definition of N3b TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in clinically detected ipsilateral internal mammary lymph nodes in the presence of one or more positive axillary lymph nodes, or in more than 3 axillary lymph nodes and in internal mammary lymph nodes with micrometastases or macrometastases detected by sentinel lymph node biopsy but not clinically detected; for gastric cancer it refers to metastases in sixteen or more regional lymph nodes; for nasopharyngeal cancer it refers to extension to the supraclavicular fossa.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E2724CD-0E63-2CEC-E040-BB89AD437A31","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3565-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"N3c","valueDescription":null,"ValueMeaning":{"publicId":"3202501","version":"1","preferredName":"N3c Stage Finding","longName":"3202501","preferredDefinition":"A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes.  The definition of N3c TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in ipsilateral supraclavicular lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N3c TNM Finding","conceptCode":"C48717","definition":"A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes.  The definition of N3c TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in ipsilateral supraclavicular lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E2724CD-0E88-2CEC-E040-BB89AD437A31","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3566-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"N4","valueDescription":null,"ValueMeaning":{"publicId":"3205589","version":"1","preferredName":"N4 Stage Finding","longName":"3205589","preferredDefinition":"A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes. The definition of N4 TNM finding depends on the specific type of cancer that it refers to; for example, for ocular adnexal lymphoma it refers to metastases to central lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N4 TNM Finding","conceptCode":"C96026","definition":"A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes. The definition of N4 TNM finding depends on the specific type of cancer that it refers to; for example, for ocular adnexal lymphoma it refers to metastases to central lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9EC7C422-8D9A-F497-E040-BB89AD43417A","latestVersionIndicator":"Yes","beginDate":"2011-03-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3567-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"NX","valueDescription":null,"ValueMeaning":{"publicId":"3202502","version":"1","preferredName":"NX Stage Finding","longName":"3202502","preferredDefinition":"A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NX TNM Finding","conceptCode":"C48718","definition":"A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E2724CD-0EAB-2CEC-E040-BB89AD437A31","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3568-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"Unknown","valueDescription":null,"ValueMeaning":{"publicId":"5682953","version":"1","preferredName":"Unknown","longName":"5682953","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B4645-0FC6-0802-E053-F662850AB305","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-3569-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"},{"value":"Not Reported","valueDescription":null,"ValueMeaning":{"publicId":"5612322","version":"1","preferredName":"Not Reported","longName":"5612322v1.00","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45340835-3B00-7C78-E053-F662850A44F9","latestVersionIndicator":"Yes","beginDate":"2017-01-03","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-01-03","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"10/10/23 changed Long Name from \"Not Stated\" to match NCIt Preferred name and current caDSR concept Long Name of \"Not Reported\" per Brenda.Janice . LS","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E26DC616-356A-67B5-E053-731AD00AD545","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"10544817","version":"1","preferredName":"Pathologic Regional Lymph Nodes TNM Finding Category","preferredDefinition":"A pathologic finding about one or more characteristics of a specific cancer, following the rules of the TNM classification system as they pertain to staging of regional lymph nodes._A grouping of items based on some commonality or by user defined characteristics.","longName":"10544817v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Regional Lymph Nodes TNM Finding","conceptCode":"C48887","definition":"A pathologic finding about one or more characteristics of a specific cancer, following the rules of the TNM classification system as they pertain to evaluating regional lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E26DC616-352A-67B5-E053-731AD00AD545","latestVersionIndicator":"Yes","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-06-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"UICC Based:Staging Criteria Based on Union for International Cancer Control","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E26DC616-352B-67B5-E053-731AD00AD545","latestVersionIndicator":"Yes","beginDate":"2022-06-30","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-30","modifiedBy":"GDEEN","dateModified":"2022-07-22","changeDescription":null,"administrativeNotes":"07.22.22_Curated to support UICC data_ghd","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"UICC Pathological N Stage","url":null,"context":"OCG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4454A1E-F364-1304-E053-731AD00A0B8F","latestVersionIndicator":"Yes","beginDate":"2022-07-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-07-20","modifiedBy":"GDEEN","dateModified":"2022-07-22","changeDescription":null,"administrativeNotes":"07.22.22_Curated to support UICC data capture_ghd","unresolvedIssues":null,"deletedIndicator":"No"}}